A genetic postmortem analysis of the brains of patients with schizophrenia suggests dysfunction of dopamine receptors in the caudate nucleus may cause the disorder. Investigators identified a ...

In the late 1950s, dopamine was recognized as a neurotransmitter in its own right. A specific functional role for dopamine was suggested by the demonstration of its uncharacteristic distribution in ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

Could coffee help to counteract some of the effects of alcohol on the brain, and potentially limit the risk of addiction? That's what's suggested by a new study of how caffeine interacts with the ...

Research has shown that dopamine (DA) plays a key role in how the body regulates the production of insulin. Typically, insulin is secreted by beta-cells in the pancreas in response to glucose—a ...

A new study has discovered complexes of dopaminergic and noradrenergic receptors that could be a therapeutic target to treat attention deficit hyperactivity disorder (ADHD) and impulsivity. The ...

SPOKANE, Wash. — One of the pressing questions that was asked during the pandemic was what the long-term effects of COVID-19 were on the body, if anything? A new study is beginning to answer that ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a fundamentally new mechanism of action in more than half a century. Built on ...

Everyone knows that friend with a tattoo of a molecule of dopamine. Usually associated with the pleasure response, it is also important in other parts of the body. Maybe next time you see that friend, ...